▶ 調査レポート

世界の細胞採取市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Cell Harvesting Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の細胞採取市場2022年-2027年:成長・動向・新型コロナの影響・市場予測 / Cell Harvesting Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) / MRC2203A148資料のイメージです。• レポートコード:MRC2203A148
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、113ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥703,000 (USD4,750)▷ お問い合わせ
  Site Licence¥962,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の本市場調査レポートでは、世界の細胞採取市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、細胞採取種類別(手動型細胞採取器、自動型細胞採取器)分析、用途別(バイオ医薬品用、幹細胞研究用、その他)分析、エンドユーザー別(バイオテクノロジー・バイオ医薬品企業、研究機関、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の細胞採取市場規模:細胞採取種類別(手動型細胞採取器、自動型細胞採取器)
・世界の細胞採取市場規模:用途別(バイオ医薬品用、幹細胞研究用、その他)
・世界の細胞採取市場規模:エンドユーザー別(バイオテクノロジー・バイオ医薬品企業、研究機関、その他)
・世界の細胞採取市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争状況(Arthrex Inc.、AVITA Medical、Cox Scientific Ltd.、…)
・市場機会・将来傾向

The major factors driving the growth of the cell harvesting market include the increasing investment in regenerative medicine and cell-based research, growth of the biotechnology and biopharmaceutical industries, and increasing incidence of chronic and infectious diseases.

According to the World Health Organization (WHO), chronic diseases are expected to increase by 57%, by 2020. Increased demand for healthcare systems due to chronic diseases has become a major concern.

The Center for Disease Control and Prevention (CDC), stated that in 2017, chronic diseases were the leading cause of death and disability in the United States, and 133 million Americans, i.e., 45% of the population, had at least one chronic disease. Also, the rise of age and lifestyle-related chronic diseases is increasing the demand for and expenditure on healthcare.

In developing markets, cancer and heart disease are becoming the main causes of death, as a result of urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. The potential use of stem cells in treating various chronic diseases is the major factor for the growth of the market. Thus, the increasing prevalence of chronic and infectious diseases is expected to spur market growth.

Key Market Trends

Stem Cell Research is Expected to be Fastest Growing Segment

  • Human stem cell research has enormous potential for contributing to the understanding of fundamental human biology. Studying stem cells is helping scientists understand more about how the human body works and how diseases develop and affect the body.
  • The research is helping researchers better understand different diseases and conditions and in finding new treatments. Human stem cell research should be integrated with mainstream biomedical research, including disease modeling, the study of cellular degenerative processes, development of pharmaceutical and toxicological screening platforms, and regenerative therapy.
  • As per the data published (2016) by the National Institute of Health, currently, around 60,000 patients are treated with bone marrow transplantation (BMT) each year, globally. Bone marrow-derived stem cells can advance the study of stem cell biology, stem cell-based therapies, and regenerative medicine.
  • Thus, due to the above-mentioned factors, the market is expected to witness high growth over the forecast period.

North America is Expected to Dominate the Cell Harvesting Market

  • North America holds a major share of the cell harvesting market, and it is expected to witness a similar trend over the forecast period, without significant fluctuations.
  • The US market is dominating the cell harvesting market because of the increasing research expenditure and government initiatives.
  • Currently, the only stem cell-based products that are approved by the FDA, for use in the United States, consist of blood-forming stem cells, derived from cord blood. These, as well as stem cells, which come from bone marrow, are commonly used in transplant procedures to treat patients with cancer and disorders of the blood and immune system. Moreover, there is a rise in healthcare expenditure in the United States.
  • These above-mentioned factors are the key elements augmenting the growth of the US market and making it stable.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of the small and large market players. Some of the market players are Arthrex Inc., AVITA Medical, GE Healthcare, Pall Corporation, Perkin Elmer Inc., Sartorius AG, Terumo Corporation, and Tomtec

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Investments in Regenerative Medicine and Cell-based Research
4.2.2 Growth of the Biotechnology and Biopharmaceutical Industries
4.2.3 Increasing Incidence of Chronic and Infectious Diseases
4.3 Market Restraints
4.3.1 Ethical Issues pertaining to Embryonic Stem Cell Research
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type of Cell Harvesting
5.1.1 Manual Cell Harvesters
5.1.2 Automated Cell Harvesters
5.2 By Application
5.2.1 Biopharmaceutical Application
5.2.2 Stem Cell Research
5.2.3 Other Applications
5.3 By End User
5.3.1 Biotechnology and Biopharmaceutical Companies
5.3.2 Research Institutes
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Arthrex Inc.
6.1.2 AVITA Medical
6.1.3 Cox Scientific Ltd.
6.1.4 Danaher Corporation
6.1.5 Perkin Elmer Inc.
6.1.6 Sartorius AG
6.1.7 Terumo Corporation
6.1.8 Tomtec

7 MARKET OPPORTUNITIES AND FUTURE TRENDS